Clinical trial Recruiting at 1 site Interventional Ages 18 and up

AI-assisted written information to support treatment for chronic anal fissure

Official title: Effect of AI-Assisted Written Patient Information on Medical Treatment Adherence and Short-Term Patient-Reported Outcomes in Primary Chronic Anal Fissure: A Prospective Randomized Controlled Trial

Run by Sanliurfa Education and Research Hospital · NCT07701811 · Data updated 2026-11-12

This trial compares AI-assisted written information to standard verbal counseling to see if people with a chronic anal fissure better stick with initial medical treatment.

More Chronic Anal Fissure trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment220 (estimated)
SponsorSanliurfa Education and Research Hospital
Government
Locations1 site (Sanliurfa)
StatusRecruiting
StartedJuly 15, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 9, 2026
Trial IDNCT07701811 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with primary chronic anal fissure planned for initial medical/conservative treatment who can read Turkish and are reachable by telephone.

Probably not a fit

Patients who are not comfortable with written information or who have factors that limit adherence despite information delivery may see no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective, randomized trial in adults with primary chronic anal fissure starting conservative treatment. Participants are randomized 1:1 to receive either standard verbal counseling or AI-assisted written information covering the same medical content. The study measures complete treatment adherence at day 14 as the primary endpoint, with secondary outcomes including pain, PGI-C, quality of life (HEMO-FISS-QoL), stool form, additional health visits, need for interventional treatment, and patient satisfaction. Assessments occur at baseline, by phone on days 7 and 14, and in person at week 6. The intervention and control differ only by the information delivery method; the medical treatment is identical across groups.

Why it matters

Potential benefit: If successful, AI-assisted written information could improve treatment adherence and patient experience during Conservative treatment for chronic anal fissure.

How similar studies have gone: Prior work suggests tailored information delivery can influence adherence in some conditions, but this specific AI-assisted, written-information approach for anal fissure is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18 years or older
2. Clinical diagnosis of primary chronic anal fissure
3. Initial medical/conservative treatment planned at first evaluation
4. Ability to read and understand Turkish
5. Reachable by telephone
6. Provision of written informed consent

Exclusion Criteria:

1. Acute anal fissure
2. Suspicion or diagnosis of secondary fissure (including Crohn's disease, tuberculosis, HIV-related lesion, suspected malignancy, or atypical lateral fissure)
3. Planned botulinum toxin, surgery, or another interventional treatment
4. History of botulinum toxin or surgical treatment for anal fissure within the last 6 months
5. Concomitant perianal abscess, fistula, advanced hemorrhoidal disease, or another significant anorectal pathology
6. Pregnancy and early postpartum period

Where it's running

  • Sanliurfa Education and Research Hospital
    Sanliurfa, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.